Blood Test News and Research

RSS

Study: Women remain at higher risk of dying or developing heart failure after a heart attack

Women face a 20 per cent higher risk than men of dying or having heart failure during the five years following a heart attack, according to a new study from University of Alberta cardiology researchers.

16 Dec 2020

Study: Patients may not be receiving recommended follow-up care after bariatric surgery

Patients who have had weight loss surgery may not be receiving follow up care from their GPs as recommended in clinical guidelines - according to new research from the University of East Anglia and the University of Birmingham.

16 Dec 2020

Huntsman Cancer Institute receives $3 million CDC grant to improve colorectal cancer screening

Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.

14 Dec 2020

AI tool helps clinical labs to rule out COVID-19

Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit.

11 Dec 2020

Circulating tumor cell dynamics linked with overall survival in patients with metastatic breast cancer

Early circulating tumor cell dynamics were associated with overall survival in patients with metastatic breast cancer, according to a meta-analysis presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.

9 Dec 2020

Measuring a tau fragment in plasma can help predict future cognitive decline in elderly people

Today, a clinician can order a blood test to check a patient's cholesterol or hemoglobin A1c levels -- biomarkers that help predict an individual's risk of cardiovascular disease or diabetes, respectively. But despite decades of advances in the understanding of Alzheimer's disease (AD), a blood test for predicting its risk remains elusive.

9 Dec 2020

New biomarker of Alzheimer's may lead to enhanced diagnostic methods

Scientists at Washington University School of Medicine, Missouri, have identified a novel form of an Alzheimer’s protein in the spinal fluid of patients.

7 Dec 2020

Blood test helps in identifying markers of COVID-19

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19).

4 Dec 2020

During ACA open enrollment, picking a plan invites new COVID complications

People buying their own health insurance have even more to think about this year, particularly those post-COVID-19 patients with lingering health concerns, the "long haulers," who join the club of Americans with preexisting conditions.

3 Dec 2020

Researchers evaluate the most appropriate test for COVID-19

Until a vaccine is available, curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined.

2 Dec 2020

Validated biomarkers can reveal individual’s risk of developing Alzheimer’s

A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual's risk of developing Alzheimer's disease.

30 Nov 2020

‘Molecular clock’ blood test could help identify actively growing tumors in metastatic breast cancer

A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumors around the body and monitor how they are responding to treatment, new research suggests.

27 Nov 2020

New algorithm accurately predicts outcomes for COVID-19 patients

With communities across the nation experiencing a wave of COVID-19 infections, clinicians need effective tools that will enable them to aggressively and accurately treat each patient based on their specific disease presentation, health history, and medical risks.

23 Nov 2020

Detectable SARS-CoV-2 antibodies 120 days post-infection in Chicago case study

In a recent study, a team of researchers at Northwestern University, USA, had found that nearly 20 percent seroprevalence in the United States metropolitan site, Chicago, over the summer, during a period when lockdown restrictions were eased. They found that three-quarters of seropositive individuals retained detectable antibodies for at least 120 days or four months.

19 Nov 2020

Blood Test News and Research

Study: Women remain at higher risk of dying or developing heart failure after a heart attack

Study: Patients may not be receiving recommended follow-up care after bariatric surgery

Huntsman Cancer Institute receives $3 million CDC grant to improve colorectal cancer screening

AI tool helps clinical labs to rule out COVID-19

Circulating tumor cell dynamics linked with overall survival in patients with metastatic breast cancer

Measuring a tau fragment in plasma can help predict future cognitive decline in elderly people

New biomarker of Alzheimer's may lead to enhanced diagnostic methods

Blood test helps in identifying markers of COVID-19

During ACA open enrollment, picking a plan invites new COVID complications

Researchers evaluate the most appropriate test for COVID-19

Validated biomarkers can reveal individual’s risk of developing Alzheimer’s

‘Molecular clock’ blood test could help identify actively growing tumors in metastatic breast cancer

New algorithm accurately predicts outcomes for COVID-19 patients

Detectable SARS-CoV-2 antibodies 120 days post-infection in Chicago case study

UK’s COVID-19 vaccine shows similar safety and immunogenicity results in healthy older adults

Noninvasive, self-administered digital tool helps assess risk for preterm delivery

Additional imaging tests can detect cause of heart attack in women with no major artery blockage

Study shows potential of new pinprick blood test for diagnosing HPV-related cancers

Losing two to three kilograms of weight can almost halve the risk of Type 2 diabetes

Blood biomarker may predict prognosis, recovery from stroke

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News